Search Results - "Palmer, Jeffrey P"
-
1
Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy
Published in Neuromuscular disorders : NMD (01-06-2020)“…•Domagrozumab at 5, 20, and 40 mg/kg was generally safe and well tolerated.•Primary endpoint of mean change from baseline in 4SC time at week 49 was not…”
Get full text
Journal Article -
2
Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trial
Published in PloS one (23-08-2022)“…Introduction The North Star Ambulatory Assessment (NSAA) tool is a key instrument for measuring clinical outcomes in patients with Duchenne muscular dystrophy…”
Get full text
Journal Article -
3
Pectin acetylesterase 8 influences pectin acetylation in the seed coat, seed imbibition, and dormancy in common bean (Phaseolus vulgaris L.)
Published in Legume science (01-09-2022)“…The results of a prior transcript profiling study identified a large difference in transcript accumulation of a pectin acetylesterase gene, designated as PAE8,…”
Get full text
Journal Article -
4
-
5
A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum
Published in The American journal of tropical medicine and hygiene (01-05-2005)“…In a randomized, double-blind, double-dummy controlled study, 22 men with erythema nodosum leprosum (ENL) received six capsules containing either 100 mg (group…”
Get more information
Journal Article -
6
Novel approaches to analysis of the North Star Ambulatory Assessment
Published in PloS one (23-08-2022)“…Introduction The North Star Ambulatory Assessment (NSAA) tool is a key instrument for measuring clinical outcomes in patients with Duchenne muscular dystrophy…”
Get full text
Journal Article -
7
Novel approaches to analysis of the North Star Ambulatory Assessment : Observations from a phase 2 trial
Published in PloS one (23-08-2022)“…Introduction The North Star Ambulatory Assessment (NSAA) tool is a key instrument for measuring clinical outcomes in patients with Duchenne muscular dystrophy…”
Get full text
Journal Article -
8
-
9
-
10
Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trial
Published in PloS one (01-01-2022)“…Introduction The North Star Ambulatory Assessment (NSAA) tool is a key instrument for measuring clinical outcomes in patients with Duchenne muscular dystrophy…”
Get full text
Journal Article -
11
Video Letters from Prison
Published in American Indian Quarterly (22-03-2011)“…[...] the concerns presented in the documentary reach far beyond the borders of Indian Country and prisons. [...] Indian people have remained skeptical of the…”
Get full text
Journal Article Book Review